Vector for tissue-specific replication and gene expression

Details for Australian Patent Application No. 2002300102 (hide)

Owner Novartis AG

Inventors Hay, Carl M; Chang, Yung-Nien; Hallenbeck, Paul L; Stewart, David A

Agent Davies Collison Cave

Pub. Number AU-A-2002300102

Parent 17552

Filing date 15 July 2002

Wipo publication date 12 December 2002

International Classifications

C12N 015/86 Mutation or genetic engineering - Viral vectors

Event Publications

12 December 2002 Application Open to Public Inspection

  Published as AU-A-2002300102

9 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300103-Improvements in and Relating to Moulding Machines

2002300101-A Lock